EUVIMEDEUVIMED entdecken
Crossref

The Biliary Stenting Strategy for the Unresectable Hilar Type of Intrahepatic Cholangiocarcinoma: A Single‐Center Experience

Cui Chen, Wen Chao Zhao iD, Ming Xing Xia, Jia Hui Zhu, Ting Ting Fu, Jun Wu, Zhi Yuan Yao, Bing Hu iD

Journal of Digestive Diseases · 2025

DOI: 10.1111/1751-2980.13350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Digestive Diseases, 2025. Verfasst von Cui Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai, China. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Stents, Klatskin Tumor, Cholangiocarcinoma. Die Arbeit nennt 30 Literaturangaben. Gefördert von: 2024 the Third Hospital Affiliated to Naval Medical University Ascend Talent Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Hilar‐type intrahepatic cholangiocarcinoma (H‐ICC), which originates from the large bile ducts, tends to invade the hepatic hilus and results in malignant hilar biliary obstruction (MHBO). Compared with hilar cholangiocarcinoma (HC), H‐ICC exhibits a more aggressive biological behavior and a dismal prognosis. We aimed to investigate the optimal biliary stenting strategy for the treatment of unresectable H‐ICC.

Methods

Patients with unresectable H‐ICC who received endoscopic biliary stenting (EBS) between January 2012 and June 2019 were retrospectively included in this study. The prognostic factors of survival outcome, clinical success, duration of stent patency, and EBS‐related adverse events were analyzed.

Results

Altogether 70 patients were enrolled, including 72.9% patients with multiple intrahepatic lesions and 44.3% with lymphatic metastasis. Jaundice control was achieved in 81.4% of the patients. Early cholangitis was the main treatment‐related complication (17.1%). After successful stenting, systematic antitumor therapy was the only independent factor related to overall survival (hazard ratio [HR] 0.381, 95% confidence interval [CI] 0.218–0.668, p = 0.001). Plastic stenting was associated with clinical success (odds ratio [OR] 0.012, 95% CI 0.008–0.549, p = 0.012), stent patency (HR 6.773, 95% CI 2.221–20.653, p = 0.001), and early cholangitis (OR 5.000, 95% CI 1.006–24.841, p = 0.049). Bismuth classification IV was independently related to stent patency (HR 4.956, 95% CI 1.245–19.730, p = 0.023).

Conclusion

For H‐ICC‐induced MHBO, metal stent placement may achieve better biliary drainage and, combined with systemic antitumor therapies, may further improve patient survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Duct NeoplasmsStentsKlatskin TumorCholangiocarcinomaHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeAged, 80 and overAdultCholangitis

Stichwörter der Autor:innen

endoscopic biliary stentinghilar‐type intrahepatic cholangiocarcinomamalignant hilar biliary obstruction

Autor:innen und Institutionen

  • Department of Gastroenterology, Eastern Hepatobiliary Surgery Hospital, Naval Military Medical University, Shanghai, China.
  • Faculty of Hepato-Pancreato-Biliary Surgery, Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Wen Chao Zhao, Bing Hu

Förderung

  • 2024 the Third Hospital Affiliated to Naval Medical University Ascend Talent Project

Zitieren

APA

Chen, C., Zhao, W. C., Xia, M. X., Zhu, J. H., Fu, T. T., Wu, J., Yao, Z. Y., & Hu, B. (2025). The Biliary Stenting Strategy for the Unresectable Hilar Type of Intrahepatic Cholangiocarcinoma: A Single‐Center Experience. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13350

Vancouver

Chen C, Zhao WC, Xia MX, Zhu JH, Fu TT, Wu J, et al. The Biliary Stenting Strategy for the Unresectable Hilar Type of Intrahepatic Cholangiocarcinoma: A Single‐Center Experience. Journal of Digestive Diseases. 2025. doi:10.1111/1751-2980.13350

BibTeX
@article{Chen2025,
  author = {Chen, Cui and Zhao, Wen Chao and Xia, Ming Xing and Zhu, Jia Hui and Fu, Ting Ting and Wu, Jun and Yao, Zhi Yuan and Hu, Bing},
  title = {The Biliary Stenting Strategy for the Unresectable Hilar Type of Intrahepatic Cholangiocarcinoma: A Single‐Center Experience},
  journal = {Journal of Digestive Diseases},
  year = {2025},
  doi = {10.1111/1751-2980.13350}
}
Kostenlos starten →